- NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Intellia Therapeutics (NTLA) S-3Shelf registration
Filed: 23 Aug 19, 5:19pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement onForm S-3 of our reports dated February 27, 2019, relating to the consolidated financial statements of Intellia Therapeutics, Inc. and the effectiveness of Intellia Therapeutics, Inc.’s internal control over financial reporting, appearing in the Annual Report onForm 10-K of Intellia Therapeutics, Inc. for the year ended December 31, 2018, and to the references to us under the headings “Experts” in the Base Prospectus and the Sales Agreement Prospectus, which are part of this Registration Statement.
/s/ Deloitte & Touche LLP |
Boston, Massachusetts |
August 23, 2019 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.